EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosis

Wooree Ko, Joseph J Porter iD, Sacha Spelier, Emily G Sorensen, Priyanka Bhatt, Jeffrey T Gabell, Isabelle van der Windt, Tyler Couch, Kevin Coote, Martin Mense, Jeffrey M Beekman, John D Lueck iD

Nucleic Acids Research · 08.07.2025 · 53 (13)

DOI: 10.1093/nar/gkaf675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 12.07.2025. Verfasst von Wooree Ko und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, United States. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Codon, Nonsense, RNA, Transfer. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cystic Fibrosis Foundation Research, NIGMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonsense mutations arise from single nucleotide substitutions that result in premature termination codons (PTCs). PTCs result in little to no full-length protein production and decreased mRNA stability due to the nonsense-mediated mRNA decay (NMD) pathway. We provide evidence that anticodon-edited (ACE-) tRNAs efficiently suppress the most prevalent cystic fibrosis (CF)-causing PTCs, promoting significant rescue of endogenous cystic fibrosis transmembrane conductance regulator (CFTR) transcript abundance and channel function in different model systems. We show that our best-performing ACE-tRNA, which decodes all UGA PTCs to a leucine amino acid, markedly rescues CFTR function from the most prevalent CF-causing PTCs, all of which arose from nonleucine encoding codons. Using this single ACE-tRNA variant, we demonstrate significant rescue of CFTR function in an immortalized airway cell line and two different primary CF patient-derived intestinal cell models with CFTR nonsense mutations. Further, we demonstrate that leucine substitution CFTR variants are highly functional. Thus, ACE-tRNAs have promise as a platform therapeutic for CF and other nonsense-associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorCodon, NonsenseRNA, TransferHumansCell LineNonsense Mediated mRNA Decay

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCodon, NonsenseCFTR protein, humanRNA, Transfer

Autor:innen und Institutionen

  • Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, United States.
  • Department of Pediatric Respiratory Medicine, Wilhelmina Children's Hospital, University Medical Center, Utrecht University, 3584 EA, Utrecht, The Netherlands.
  • Regenerative Medicine Utrecht, University Medical Center, Utrecht University, 3584 CT, Utrecht, The Netherlands.
  • Cystic Fibrosis Foundation Therapeutics Lab, Cystic Fibrosis Foundation, Lexington, MA 02421, United States.
  • Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, United States.
  • Centre for Living Technologies, Alliance Eindhoven University of Technology, Wageningen University and Research, Utrecht University, University Medical Center Utrecht, Utrecht 3584 CB, The Netherlands.

ORCID-Profile: Joseph J Porter, John D Lueck

Förderung

  • Cystic Fibrosis Foundation Research
  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • Cystic Fibrosis Foundation Postdoctoral
  • Emily’s Entourage
  • NIH
  • National Institute of General Medical Science

Zitieren

APA

Ko, W., Porter, J. J., Spelier, S., Sorensen, E. G., Bhatt, P., Gabell, J. T., van der Windt, I., Couch, T., Coote, K., Mense, M., Beekman, J. M., & Lueck, J. D. (2025). ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosis. Nucleic Acids Research, 53(13). https://doi.org/10.1093/nar/gkaf675

Vancouver

Ko W, Porter JJ, Spelier S, Sorensen EG, Bhatt P, Gabell JT, et al. ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosis. Nucleic Acids Research. 2025;53(13). doi:10.1093/nar/gkaf675

BibTeX
@article{Ko2025,
  author = {Ko, Wooree and Porter, Joseph J and Spelier, Sacha and Sorensen, Emily G and Bhatt, Priyanka and Gabell, Jeffrey T and van der Windt, Isabelle and Couch, Tyler and Coote, Kevin and Mense, Martin and Beekman, Jeffrey M and Lueck, John D},
  title = {ACE-tRNAs are a platform technology for suppressing nonsense mutations that cause cystic fibrosis},
  journal = {Nucleic Acids Research},
  year = {2025},
  volume = {53},
  number = {13},
  doi = {10.1093/nar/gkaf675}
}
Kostenlos starten →